Effect of a glucagon receptor antibody (REMD-477) in type 1 diabetes: A randomized controlled trial

Jeremy Pettus, Dominic Reeds, Tricia S. Cavaiola, Schafer Boeder, Michelle Levin, Garry Tobin, Edda Cava, Dung Thai, Jim Shi, Hai Yan, Edgar Bautista, John McMillan, Roger Unger, Robert R. Henry, Samuel Klein

Research output: Contribution to journal › Article › peer-review

53 Scopus citations

Fingerprint

Dive into the research topics of 'Effect of a glucagon receptor antibody (REMD-477) in type 1 diabetes: A randomized controlled trial'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology